Skip to content
LivFulNEWMA

From authorized knowledge to evidence-backed discovery decisions

NEWMA is a proposed platform that connects authorized ethnobotanical knowledge and authenticated botanical materials to computational prioritization, controlled experiments and scientist-approved observations, while keeping source attribution, confidentiality and benefit obligations attached.

The demo uses synthetic data and is not evidence of scientific performance, deployment or compliance.

NEWMA ecosystem diagramSix proposed components drawn as stacked slabs, each linking to its page. Interface passes requests to Agentic Compute, which sends results to Scientific Review and work to Wet Lab; Wet Lab results return to Scientific Review. Every component relies on Data & Knowledge for authoritative records. Provenance & DLT is an optional extension.InterfaceWhere people sign inAgentic ComputePlans screening runsScientific ReviewScientists decideWet LabAssays and resultsData & KnowledgeAuthoritative recordsProvenance & DLTOptional ledger layer

Select a component to open its page.

Keyboard help
  • Tab and Shift+Tab move between components.
  • When animation is on, the arrow keys, Home and End also move between components.
  • Enter opens the focused component.
  • Escape puts the layers back together.
  • On a touch screen, the first tap separates the layers and the second tap opens a component, or use Explore components.
  • With reduced motion the diagram stays separated and only Tab applies.
Illustrative diagram. Glyphs are abstract and do not depict real species or deployed systems.

What NEWMA is

NEWMA is proposed as a hybrid computational and experimental platform for ethnobotanical drug discovery.

The problem it addresses

Discovery decisions stall because knowledge, physical material, chemical identity and biological evidence are hard to connect reliably.

How it works

  1. Agentic discovery

    A scientist submits a query, an objective and constraints. The agent is designed to check access and rights first, retrieve only within the authorized scope, and return ranked hypotheses with their limitations.

  2. Durable screening

    Screening requests are designed to run as durable workflows with budgets, bounded retries, cancellation and holds, recording inputs, versions, settings and seeds.

  3. Wet-lab loop

    Scientists approve assay requests. Results return with raw data, replicates and uncertainty, and only observations a scientist accepts count as evidence.

  4. Signed provenance

    Decisions and records are designed to carry signed, versioned provenance. A ledger layer is an optional extension, and authoritative records stay off-chain.

Computational outputs remain hypotheses. Scientists approve experimental work and advancement.

See the demo

Who it is for

  • Computational biologist

    Needs reliable chemical identities, reproducible runs and a clear reason a candidate merits testing.

  • Wet-lab scientist or CRO

    Needs unambiguous materials, protocols and controls, so accepted observations link to the right batch and hypothesis.

  • Indigenous community liaison

    Needs understandable consent, control over disclosure and visible benefit obligations, without exposing confidential knowledge.

  • Biopharma partner

    Needs secure discovery access and traceable evidence to judge scientific and commercial readiness.

Supporting roles include tenant administrators, scientific approvers, data stewards, legal reviewers and security operators.

About LivFul

Mission

LivFul exists to enable research teams to turn authorized knowledge and authenticated materials into reproducible, experimentally supported decisions, preserving attribution, confidentiality and benefit obligations.

Vision

A rights-aware evidence system, scientist-supervised computation and an assay feedback loop, built on shared infrastructure.

Approach

  • A rights-aware evidence system connects botanical knowledge to authenticated materials and curated structures.
  • Scientist-supervised computation prioritizes the experiments worth running.
  • An assay feedback loop records confirmed activity, failures and development liabilities.

These are design goals for a proposed platform, not results achieved.